Tuberous Sclerosis Clinical Trial
— RAINBOWOfficial title:
Assessment and Treatment of Behavior Problems in TSC at Preschool Age: A Telehealth Approach
The RAINBOW study is a fully remote study focused on understanding and treating behavior problems in young children with tuberous sclerosis complex (TSC). The first goal is to enroll a group of 100 children with TSC between the ages of 3 and 6 years old, with and without problem behaviors, to learn about how best to measure behavioral challenges in TSC and how common these behaviors are during this age period. All families will get feedback from the clinical assessments collected. Eligible children who are experiencing behavior problems will be invited to enroll in a pilot clinical trial of internet-based Parent-Child Interaction Therapy (or PCIT), which is meant to help parents better manage their children's challenging behaviors. Adaptations to PCIT are incorporated to suit the needs of TSC children and families. Some participants will be randomly selected to receive the intervention immediately and others after a 6-month delay, but all families will receive the same intervention. Intervention sessions occur on a weekly basis for up to 20 weeks. Follow-up assessments, which include play interactions, parent interviews, and questionnaires occur about 3 and 6 months after the first visit. The delayed treatment group has an extra brief assessment about 12 months from the initial visit. This study will increase what is known about the types of behavior problems that come up during preschool age in TSC and how best to help children and families with TSC who are experiencing these problems.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | July 31, 2025 |
Est. primary completion date | April 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 6 Years |
Eligibility | Inclusion Criteria: For assessment visit: - Clinical diagnosis of TSC - Chronological age of 3 years, 0 months to 6 years, 11 months old at enrollment. - English or Spanish as primary language in the home. For intervention study only: - Elevated behavior problems - Parent/caregiver available to participate in PCIT Exclusion Criteria: For assessment visit: - None For intervention study: - Plan for epilepsy surgery during study period - Receptive communication skills below 18-month level |
Country | Name | City | State |
---|---|---|---|
United States | University of California, Los Angeles | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Eyberg Child Behavior Inventory (ECBI) | The ECBI is a norm-referenced caregiver report measure of disruptive behavior in children. | Baseline, 3-month follow-up, 6-month follow-up, 12-month follow-up (delayed treatment group only) | |
Secondary | Behavior Assessment Scale for Children-3rd Edition (BASC-3) | The BASC-3 is a norm-referenced caregiver report measure of broad behavior problems and adaptive skills in children. | Baseline, 6-month follow-up | |
Secondary | Vineland Adaptive Behavior Scales-3rd Edition (Vineland-3) | The Vineland-3 is a norm-referenced caregiver report measure of adaptive skills for infancy through adulthood. Communication, daily living, socialization, and motor skills are measured. The parent interview version is used for this study. | Baseline, 6-month follow-up | |
Secondary | Parenting Stress Index-4th Edition-Short Form (PSI-4-SF) | The PSI-4-SF is a norm-referenced self-report measure of parenting-related stress. | Baseline, 6-month follow-up | |
Secondary | Dyadic Parent-Child Interaction Coding System (DPICS) | The DPICS measures parent-child interactions across 3 situations: child led play, parent led play, and clean up. Language and behavior are coded according to the DPICS-IV coding system. | Baseline, 3-month follow-up, 6-month follow-up, 12-month follow-up (delayed treatment group only) | |
Secondary | Therapy Attitude Index (TAI) | The TAI measures treatment acceptability in PCIT. | 6-month follow-up (immediate treatment), 12-month follow-up (delayed treatment) | |
Secondary | Telehealth Usability Questionnaire (TUQ) | The TUQ measures comfort with the use of telehealth methods pre- and post-treatment. | Baseline & 6-month follow-up (immediate treatment), 6-month follow-up & 12-month follow-up (delayed treatment) | |
Secondary | Aberrant Behavior Checklist (ABC) | The ABC is a caregiver report questionnaire commonly used to measure problem behaviors and behavior change in children and adults with disabilities. | Baseline, 6-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
Recruiting |
NCT00001532 -
Role of Genetic Factors in the Development of Lung Disease
|
||
Completed |
NCT00552955 -
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
|
||
Recruiting |
NCT03422367 -
JASPER Early Intervention for Tuberous Sclerosis
|
N/A | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Unknown status |
NCT00490789 -
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
|
Phase 2 | |
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Recruiting |
NCT06065852 -
National Registry of Rare Kidney Diseases
|
||
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT02104011 -
Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
|
Phase 2 | |
Recruiting |
NCT02461459 -
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
|
||
Completed |
NCT01526356 -
Topical Rapamycin to Erase Angiofibromas in TSC
|
Phase 2 | |
Withdrawn |
NCT03254680 -
Turmeric as Treatment in Epilepsy
|
N/A | |
Terminated |
NCT01092208 -
Studies of Autistic Patients: Gene Networks and Clinical Subtypes
|
||
Active, not recruiting |
NCT01954693 -
A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
|
Phase 2 | |
Completed |
NCT03826628 -
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
|
Phase 2/Phase 3 | |
Completed |
NCT00989742 -
Doxycycline In Lymphangioleiomyomatosis (LAM)
|
Phase 4 | |
Recruiting |
NCT05286632 -
KidneYou - Innovative Digital Therapy
|
N/A | |
Withdrawn |
NCT04344626 -
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
|
N/A | |
Recruiting |
NCT05199402 -
Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases
|